12-O-Tetradecanoyl Phorbol 13-Acetate, Protein Kinase C (PKC) Activator, Protects Human Leukemia HL-60 Cells from Taxol-Induced Apoptosis: Possible Role for Extracellular Signal-Regulated Kinase

References

• Papadimitriou C. A., Sarris K., Moulopoulos L. A., Fountzilas G., Anagnostopoulos A., Voulgaris Z., Gika D., Giannakoulis N., Diakomanolis E., Imopoulos M. A. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J. Clin. Oncol. 1999; 17: 761–766
   PubMed Web of Science ®Google Scholar
• Sekine I., Nishiwaki Y., Watanabe K., Yoneda S., Saijo N. Phase II study of 3-hour infusion of paclitaxel in previously untreated non-small cell lung cancer. Clin. Cancer Res. 1996; 2: 941–945
   PubMed Web of Science ®Google Scholar
• Ojima I., Chakravarty S., Inoue T., Lin S., He L., Horwitz S. B., Kuduk S. D., Danishefsky S. J. A common pharmacophore for cytotoxic natural products that stabilize microtubules. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 4256–4261
   PubMed Web of Science ®Google Scholar
• Lieu C. H., Chang Y. N., Lai Y. K. Dual cytotoxic mechanisms of submicromolar taxol on human leukemia HL-60 cells. Biochem. Pharmacol. 1997; 53: 1587–1596
   PubMedGoogle Scholar
• Rathmell J. C., Thompson C. B. The central effectors of cell death in the immune system. Annu. Rev. Immunol. 1999; 17: 781–828
   PubMed Web of Science ®Google Scholar
• Glazer R. I. The protein kinase ABC's of signal transduction as targets for drug development. Curr. Pharm. Des. 1998; 4: 277–290
   PubMed Web of Science ®Google Scholar
• Kyriakis J. M. Making the connection: coupling of stress-activated ERK / MAPK (extracellular-signal-regulated kinase / mitogen-activated protein kinase) core signalling modules to extracellular stimuli and biological responses. Biochem. Soc. Symp. 1999; 64: 29–48
   PubMedGoogle Scholar
• Terada Y., Nakashima O., Inoshita S., Kuwahara M., Sasaki S., Marumo F. Mitogen-activated protein kinase cascade and transcription factors: the opposite role of MKK3 / 6-p38K and MKK1-MAPK. Nephrol. Dial. Transplant. 1999; 14: 45–47
   PubMedGoogle Scholar
• Neary J. T., Kang Y., Bu Y., Yu E, Akong K., Peters C. M. Mitogenic signaling by ATP / P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C / calcium pathway. J. Neurosci. 1999; 19: 4211–4220
   PubMed Web of Science ®Google Scholar
• Miranti C. K., Ohno S., Brugge J. S. Protein kinase C regulates integrin-induced activation of the extracellular regulated kinase pathway upstream of Shc. J. Biol. Chem. 1999; 274: 10571–1081
   PubMed Web of Science ®Google Scholar
• Bhalla K., Ibrado A. M., Tourkina E., Tang C., Mahoney M. E., Huang Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 1993; 7: 563–568
   PubMed Web of Science ®Google Scholar
• Kang J. J., Chen I. L., Yen-Yang H. F. Mediation of gamma-hexachlorocyclohexane-induced DNA fragmentation in HL-60 cells through intracellular Ca2+ release pathway. Food Chem. Toxicol. 1998; 36: 513–520
   PubMedGoogle Scholar
• Tokuda H., Kozawa O., Harada A., Uematsu T. p42 / p44 mitogen-activated protein kinase activation is involved in prostaglandin F2alpha-induced interleukin-6 synthesis in osteoblasts. Cell Signal 1999; 11: 325–330
   PubMedGoogle Scholar
• Wang S., Guo C. Y., Castillo A., Dent P., Grant S. Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937). Biochem. Pharmacol. 1998; 56: 635–644
   PubMed Web of Science ®Google Scholar
• Stadheim T. A., Kucera G. L. Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis. Biochem. Biophys. Res. Commun. 1998; 245: 266–271
   PubMed Web of Science ®Google Scholar
• Merritt J. E., Sullivan J. A., Drew L., Khan A., Wilson K., Mulqueen M., Harris W., Bradshaw D., Hill C. H., Rumsby M, Warr R. The bisindolylmaleimide protein kinase C inhibitor, Ro32–2241, reverses multidrug resistance in KB tumour cells. Cancer Chemother. Pharmacol. 1999; 43: 371–378
   PubMed Web of Science ®Google Scholar
• Masanek U., Stammler G., Volm M. Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin. Anticancer Drugs 1997; 8(2)189–198
   PubMedGoogle Scholar
• Volm M., Zintl F., Edler L., Sauerbrey A. Prognostic value of protein kinase C., proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia. Med. Pediatr. Oncol. 1997; 28: 117–26
   PubMedGoogle Scholar
• Jun C. D., Pae H. O., Kwak H. J., Yoo J. C., Choi B. M., Oh C. D., Chun J. S., Paik S. G., Park Y. H., Chung H. T. Modulation of nitric oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways. Cell Immunol. 1999; 194: 36–46
   PubMed Web of Science ®Google Scholar
• Cuvillier O., Pirianov G., Kleuser B., Vanek P. G., Coso O. A., Gutkind S., Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-l-phosphate. Nature 1996; 381(6585)800–3; 800–803
   PubMed Web of Science ®Google Scholar